On Tuesday, Humana Inc (NYSE: HUM) was -0.84% drop from the session before settling in for the closing price of $282.44. A 52-week range for HUM has been $213.31 – $527.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 13.38%. When this article was written, the company’s average yearly earnings per share was at -38.10%. With a float of $120.11 million, this company’s outstanding shares have now reached $122.22 million.
Let’s determine the extent of company efficiency that accounts for 67600 employees. In terms of profitability, gross margin is 88.39%, operating margin of 2.28%, and the pretax margin is 1.73%.
Humana Inc (HUM) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Humana Inc stocks. The insider ownership of Humana Inc is 0.25%, while institutional ownership is 97.18%. The most recent insider transaction that took place on Feb 20 ’24, was worth 200,066. In this transaction Director of this company bought 545 shares at a rate of $367.09, taking the stock ownership to the 2,578 shares.
Humana Inc (HUM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -38.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.51% during the next five years compared to 10.46% growth over the previous five years of trading.
Humana Inc (NYSE: HUM) Trading Performance Indicators
You can see what Humana Inc (HUM) is doing with its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.29, a number that is poised to hit -2.05 in the next quarter and is forecasted to reach 17.29 in one year’s time.
Technical Analysis of Humana Inc (HUM)
Looking closely at Humana Inc (NYSE: HUM), its last 5-days average volume was 2.66 million, which is a jump from its year-to-date volume of 1.87 million. As of the previous 9 days, the stock’s Stochastic %D was 69.43%. Additionally, its Average True Range was 12.13.
During the past 100 days, Humana Inc’s (HUM) raw stochastic average was set at 34.56%, which indicates a significant decrease from 61.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.40% in the past 14 days, which was higher than the 45.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $286.28, while its 200-day Moving Average is $335.71. However, in the short run, Humana Inc’s stock first resistance to watch stands at $285.95. Second resistance stands at $291.84. The third major resistance level sits at $297.69. If the price goes on to break the first support level at $274.21, it is likely to go to the next support level at $268.36. Should the price break the second support level, the third support level stands at $262.47.
Humana Inc (NYSE: HUM) Key Stats
There are 120,411K outstanding shares of the company, which has a market capitalization of 33.72 billion. As of now, sales total 106,374 M while income totals 2,489 M. Its latest quarter income was 29,397 M while its last quarter net income were 480,000 K.
